What does Pulse Biosciences, Inc. do?
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp…
What is Pulse Biosciences, Inc.'s P/E and P/B ratio?
Pulse Biosciences, Inc. has a P/E ratio of -44.6 and a P/B ratio of 37.76.
What is Pulse Biosciences, Inc.'s debt-to-equity ratio?
Pulse Biosciences, Inc. has a debt-to-equity ratio of 0.07.
How much does Pulse Biosciences, Inc. owe compared with what it owns?
Pulse Biosciences, Inc. owes $0.14 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Pulse Biosciences, Inc.'s Positivity rank?
Pulse Biosciences, Inc. is ranked #6,199 of 6,774 companies globally and #3,528 of 4,000 in United States on PositoAI, with a Positivity Score of 3,376.
Does Pulse Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Pulse Biosciences, Inc..
Where can I read the latest news about Pulse Biosciences, Inc.?
Recent headlines about Pulse Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Pulse Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Pulse Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.